BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36543869)

  • 21. Effect of Electronic Cigarettes on Smoking Reduction and Cessation in Korean Male Smokers: A Randomized Controlled Study.
    Lee SH; Ahn SH; Cheong YS
    J Am Board Fam Med; 2019; 32(4):567-574. PubMed ID: 31300577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolomic Analysis Identified Reduced Levels of Xenobiotics, Oxidative Stress, and Improved Vitamin Metabolism in Smokers Switched to Vuse Electronic Nicotine Delivery System.
    Liu G; Lin CJ; Yates CR; Prasad GL
    Nicotine Tob Res; 2021 Jun; 23(7):1133-1142. PubMed ID: 33165576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nicotine pharmacokinetics and subjective response among adult smokers using different flavors of on!® nicotine pouches compared to combustible cigarettes.
    Rensch J; Liu J; Wang J; Vansickel A; Edmiston J; Sarkar M
    Psychopharmacology (Berl); 2021 Nov; 238(11):3325-3334. PubMed ID: 34432106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reductions in biomarkers of exposure to selected harmful and potentially harmful constituents following exclusive and partial switching from combustible cigarettes to myblu
    Morris P; McDermott S; Chapman F; Verron T; Cahours X; Stevenson M; Thompson J; Chaudhary N; O'Connell G
    Intern Emerg Med; 2022 Mar; 17(2):397-410. PubMed ID: 34435305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Randomised Study to Investigate the Nicotine Pharmacokinetics of Oral Nicotine Pouches and a Combustible Cigarette.
    McEwan M; Azzopardi D; Gale N; Camacho OM; Hardie G; Fearon IM; Murphy J
    Eur J Drug Metab Pharmacokinet; 2022 Mar; 47(2):211-221. PubMed ID: 34923602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of FDA's Vuse market authorisation: limitations and opportunities.
    Meshnick AB; Faricy LE; Lushniak BD
    Tob Control; 2024 Mar; 33(e1):e116-e121. PubMed ID: 36764685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Naturalistic assessment of demand for cigarettes, snus, and nicotine gum.
    Stein JS; Wilson AG; Koffarnus MN; Judd MC; Bickel WK
    Psychopharmacology (Berl); 2017 Jan; 234(2):245-254. PubMed ID: 27730273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in nicotine intake and effects from electronic and combustible cigarettes among dual users.
    St Helen G; Nardone N; Addo N; Dempsey D; Havel C; Jacob P; Benowitz NL
    Addiction; 2020 Apr; 115(4):757-767. PubMed ID: 31691397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the Pharmacokinetics of Nicotine Following Single and Ad Libitum Use of a Tobacco Heating System or Combustible Cigarettes.
    Picavet P; Haziza C; Lama N; Weitkunat R; Lüdicke F
    Nicotine Tob Res; 2016 May; 18(5):557-63. PubMed ID: 26438645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of reduced-risk nicotine-delivery products on smoking prevalence and cigarette sales: an observational study.
    Pesola F; Phillips-Waller A; Beard E; Shahab L; Sweanor D; Jarvis M; Hajek P
    Public Health Res (Southampt); 2023 Sep; 11(7):1-39. PubMed ID: 37795840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of subjective responses in electronic cigarette uptake and substitution in adult smokers.
    Gades MS; Petersen A; Meier E; Lindgren BR; O'Connor RJ; Shields PG; Hatsukami D
    Drug Alcohol Depend; 2020 Jul; 212():107999. PubMed ID: 32409110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Twenty-four-hour subjective and pharmacological effects of ad-libitum electronic and combustible cigarette use among dual users.
    Harvanko AM; St Helen G; Nardone N; Addo N; Benowitz NL
    Addiction; 2020 Jun; 115(6):1149-1159. PubMed ID: 31837232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Room air constituent concentrations from use of electronic nicotine delivery systems and cigarettes using different ventilation conditions.
    Oldham MJ; Sehgal A; Cohen G; Chen J; Evans B; Heraldez D
    Sci Rep; 2021 Jan; 11(1):1736. PubMed ID: 33462299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood Nicotine Predicts the Behavioral Economic Abuse Liability of Reduced-Nicotine Cigarettes.
    Kaplan BA; Crill EM; Franck CT; Bickel WK; Koffarnus MN
    Nicotine Tob Res; 2022 Mar; 24(5):728-735. PubMed ID: 34865118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomised, open-label, cross-over clinical study to evaluate the pharmacokinetic, pharmacodynamic and safety and tolerability profiles of tobacco-free oral nicotine pouches relative to cigarettes.
    Chapman F; McDermott S; Rudd K; Taverner V; Stevenson M; Chaudhary N; Reichmann K; Thompson J; Nahde T; O'Connell G
    Psychopharmacology (Berl); 2022 Sep; 239(9):2931-2943. PubMed ID: 35732751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nicotine delivery and users' reactions to Juul compared with cigarettes and other e-cigarette products.
    Hajek P; Pittaccio K; Pesola F; Myers Smith K; Phillips-Waller A; Przulj D
    Addiction; 2020 Jun; 115(6):1141-1148. PubMed ID: 31994254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in Biomarkers of Cigarette Smoke Exposure After 6 Days of Switching Exclusively or Partially to Use of the JUUL System with Two Nicotine Concentrations: A Randomized Controlled Confinement Study in Adult Smokers.
    Cohen G; Goldenson NI; Bailey PC; Chan S; Shiffman S
    Nicotine Tob Res; 2021 Nov; 23(12):2153-2161. PubMed ID: 34161586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reductions in biomarkers of exposure, impacts on smoking urge and assessment of product use and tolerability in adult smokers following partial or complete substitution of cigarettes with electronic cigarettes.
    D'Ruiz CD; Graff DW; Robinson E
    BMC Public Health; 2016 Jul; 16():543. PubMed ID: 27401980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomised controlled single-centre open-label pharmacokinetic study to examine various approaches of nicotine delivery using electronic cigarettes.
    Ebajemito JK; McEwan M; Gale N; Camacho OM; Hardie G; Proctor CJ
    Sci Rep; 2020 Nov; 10(1):19980. PubMed ID: 33235307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nicotine pharmacokinetic profiles of the Tobacco Heating System 2.2, cigarettes and nicotine gum in Japanese smokers.
    Brossard P; Weitkunat R; Poux V; Lama N; Haziza C; Picavet P; Baker G; Lüdicke F
    Regul Toxicol Pharmacol; 2017 Oct; 89():193-199. PubMed ID: 28760390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.